1. Shin, Gyu-Tae, Park, Ji Eun, Lee, Min-Jeong. 2021. MAGEH1 interacts with GADD45G and induces renal tubular cell apoptosis. In PloS one, 16, e0260135. doi:10.1371/journal.pone.0260135. https://pubmed.ncbi.nlm.nih.gov/34788311/
2. Wang, Peng-Cheng, Hu, Zhi-Qiang, Zhou, Shao-Lai, Luo, Chu-Bin, Huang, Xiao-Wu. 2018. Downregulation of MAGE family member H1 enhances hepatocellular carcinoma progression and serves as a biomarker for patient prognosis. In Future oncology (London, England), 14, 1177-1186. doi:10.2217/fon-2017-0672. https://pubmed.ncbi.nlm.nih.gov/29316827/
3. De Donato, Marcos, Peters, Sunday O, Hussain, Tanveer, Babar, Masroor E, Imumorin, Ikhide G. 2017. Molecular evolution of type II MAGE genes from ancestral MAGED2 gene and their phylogenetic resolution of basal mammalian clades. In Mammalian genome : official journal of the International Mammalian Genome Society, 28, 443-454. doi:10.1007/s00335-017-9695-6. https://pubmed.ncbi.nlm.nih.gov/28516231/
4. Ojima, Hidenori, Yoshikawa, Daitaro, Ino, Yoshihiro, Kanai, Yae, Shibata, Tatsuhiro. 2009. Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment. In Cancer science, 101, 882-8. doi:10.1111/j.1349-7006.2009.01462.x. https://pubmed.ncbi.nlm.nih.gov/20088962/
5. Zhu, Yimiao, Zhao, Yu, Cao, Zhongsheng, Chen, Zhihao, Pan, Wensheng. 2022. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma. In Gene, 818, 146177. doi:10.1016/j.gene.2021.146177. https://pubmed.ncbi.nlm.nih.gov/35065254/
6. Arora, Mohit, Kumari, Sarita, Singh, Jay, Chopra, Anita, Chauhan, Shyam S. 2020. Downregulation of Brain Enriched Type 2 MAGEs Is Associated With Immune Infiltration and Poor Prognosis in Glioma. In Frontiers in oncology, 10, 573378. doi:10.3389/fonc.2020.573378. https://pubmed.ncbi.nlm.nih.gov/33425727/
7. Tang, Rong, Liu, Xiaomeng, Wang, Wei, Yu, Xianjun, Shi, Si. 2021. Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma. In Frontiers in oncology, 11, 643465. doi:10.3389/fonc.2021.643465. https://pubmed.ncbi.nlm.nih.gov/33912458/
智鼠故事 
